Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Apyx Medical Corporation logo

Apyx Medical Corporation

Sector: Healthcare   

Industry: Medical Instruments & Supplies

1.60
 
USD
  
0.00
  
(0.00%)
Optionable: Yes  Market Cap: 49 M  90-day average vol: 153,742

Previous close: 1.6  Open: 1.6  Bid: 1.57  Ask: 1.99
52 week range    
1.21   
   7.97
Peers   
NUVA / 
NVCN-CA / 
NURO / 
Last updated: Wednesday 22nd May 2024
52
MarketXLS Rank
60
Value
46
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

APYX Income Statement

Annual
Dec-12Dec-13Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends3 M932000.0
Amortization of intangibles0.0-100000.0-100000.0-100000.0
Basic EPS from continuing operations-0.4-1.03-0.14-0.77-0.58-0.35-0.44-0.67
Basic EPS total0.04-0.4-1.03-0.14-0.51.89-0.58-0.35-0.44-0.67
Basic weighted shares outstanding17631.017670.018 M27 M31 M33 M34 M34 M34 M35 M
BasicDiscontinuousOperations0.272.21
Cost of sales-16 M14 M19 M19 M3 M-6 M9 M10 M15 M15 M
Depreciation-734000.0-600000.0-400000.0-700000.0700000.0700000.0700000.0
DepreciationAndAmortization-734000.0-600000.0-400000.0-700000.0700000.0700000.0700000.0
Diluted EPS total0.03-0.4-1.03-0.150.271.83-0.58-0.35-0.44-0.67
Diluted normalized net income/share-0.4-1.03-0.15-0.17-0.58-0.44-0.67
Diluted weighted shares outstanding17787.017670.018 M27 M31 M34 M34 M34 M35 M
DilutedDiscontinuousOperations0.272.14
Fees-543000.0
GainOnSaleOfSecurity20000.0-842000.0-7 M64000.0183000.020000.0
GainsLossOnDisposalOfDiscontinuedOperations0.068 M
GeneralAndAdministrativeExpense1 M8 M8 M10 M10 M3 M9 M19 M26 M30 M
Gross operating profit11 M9 M9 M18 M7 M11 M19 M18 M34 M29 M
Income before tax834000.0-6 M-13 M-4 M-14 M-15 M-20 M-19 M-15 M-23 M
Income restructuring and M&A-160000.00.02 M741000.0
Income taxes-217000.0-2 M4 M64000.0-156000.0-4 M-130000.0-8 M380000.0367000.0
InterestExpenseNonOperating237000.0151000.0158000.0136000.0104000.08000.046000.010000.015000.0
InterestIncomeOperating0.0616000.01 M241000.011000.0157000.0
MinorityInterests10000.028000.094000.0
MiscOtherSpecialCharges20000.0-664000.011 M-415000.01 M200000.0
Net income from total operations1 M-4 M-17 M-4 M-14 M58 M-20 M-12 M-15 M-23 M
NetIncomeCommonStockholders1 M-7 M-18 M-4 M-14 M58 M-20 M-12 M-15 M-23 M
NetIncomeContinuousOperations1 M-4 M-17 M-4 M-14 M58 M-20 M-12 M-15 M-23 M
NetIncomeDiscontinuousOperations68 M
NetNonOperatingInterestIncomeExpense-237000.0-151000.0-158000.0-136000.0-104000.0-8000.0-46000.0-10000.0-15000.0
NetOperatingInterestIncomeExpense-232000.0
NonRecurringOperationExpense2 M
Operating income1 M-4 M-6 M-4 M-12 M-14 M-21 M-20 M-14 M-24 M
Operating income before depreciation (EBITDA)2 M-5 M-12 M-3 M-13 M-14 M-19 M-18 M-14 M-22 M
OperatingExpense10 M13 M15 M22 M19 M-25 M40 M38 M48 M53 M
Other income net-20000.02 M7 M-64000.0-183000.0-20000.0-1 M-200000.0
OtherGandA1 M8 M8 M10 M10 M3 M9 M19 M26 M30 M
OtherOperatingExpenses0.0947000.0351000.0-479000.0373000.0-509000.0
OtherunderPreferredStockDividend3 M932000.0
PreferredStockDividends3 M932000.0
PromotionAndAdvertising-277000.00.0-700000.0-600000.0-800000.0-1 M800000.01 M2 M
RentAndLandingFees-256000.0-228000.0-72000.00.0
Research & development expense1 M1 M1 M3 M2 M3 M4 M4 M4 M5 M
ResearchExpense1 M1 M1 M3 M2 M3 M4 M4 M4 M5 M
RestructringAndMnAIncome-160000.00.02 M741000.0
Revenue per share-108000.0-100000.0-100000.0-100000.0-57000.0216000.0216000.0138000.0
SalariesAndWages3 M4 M6 M9 M7 M9 M14 M15 M18 M19 M
Selling Gen & administrative expense6 M8 M8 M10 M10 M13 M22 M19 M26 M30 M
SellingAndMarketingExpense4 M-305000.0-700000.0-600000.09 M14 M800000.01 M2 M
SellingExpense4 M9 M14 M
Special income/charges160000.0-2 M-2 M-741000.0
Total Income available for interest expense (EBIT)834000.0-6 M-13 M-4 M-14 M-15 M-20 M-19 M-15 M-23 M
Total common shares outstanding18 M18 M18 M31 M33 M34 M34 M34 M34 M35 M
Total net income1 M-4 M-17 M-4 M-14 M58 M-20 M-12 M-15 M-23 M
Total ordinary shares35 M35 M35 M35 M35 M35 M35 M35 M35 M35 M
Total revenues28 M24 M28 M37 M10 M17 M28 M28 M49 M45 M
TotalExpenses-6 M27 M34 M40 M23 M-31 M49 M48 M63 M-68 M
TotalRevenue28 M23 M28 M37 M10 M17 M28 M28 M49 M45 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University